U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
SUVIZUMAB
INN   WHO-DD  
INN  
Official Name English
suvizumab [INN]
Preferred Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) ENVELOPE GLYCOPROTEIN GP120 THIRD VARIABLE LOOP V3), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
Suvizumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C281
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL1743074
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
PRIMARY
WIKIPEDIA
Suvizumab
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
PRIMARY
NCI_THESAURUS
C152483
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
PRIMARY
FDA UNII
4AJ2TI6DPI
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
PRIMARY
CAS
914257-21-9
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
PRIMARY
SMS_ID
300000021896
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
PRIMARY
INN
9185
Created by admin on Mon Mar 31 23:02:53 GMT 2025 , Edited by admin on Mon Mar 31 23:02:53 GMT 2025
PRIMARY
ACTIVE MOIETY
SUVIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966